Ashley Drake
Adult Health · Cullman, ALNPI 1831562321
Payments from drug & device makers
Across 25 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$151
- AstraZeneca$116
- Takeda Pharmaceuticals U.S.A., Inc.$81
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$26
- Lilly USA, LLC$21
- Amarin Pharma, Inc.$18
- plus $44 from 3 others
What the payments were for
- Food & beverage$456100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 9 | $151 |
| AstraZeneca | 6 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $26 |
| Lilly USA, LLC | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $12 |
How this compares
$456 in reported general payments places this provider in the 50th percentile of 308 adult health providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 54 | $11,404 |
| Cefdinir | 138 | $2,849 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 143 | $1,543 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $891 |
| Fluticasone Propionate | 46 | $483 |
| Losartan Potassium | 20 | $269 |
| Levothyroxine Sodium | 18 | $235 |
| Azithromycin | 54 | $216 |
| Metoprolol Succinate | 22 | $209 |
| Methylprednisolone | 24 | $208 |
| Cephalexin | 26 | $178 |
| Prednisone | 91 | $161 |
| Atorvastatin Calcium | 24 | $149 |
| Fluconazole | 23 | $130 |
| Ondansetron OdtOndansetron | 14 | $112 |
Paid to pharmacies, not to this prescriber.
Other adult health in Cullman
- Katherine MannCullman$3K
- Wendy CantrellMountain Brk$276K
- Lanier OhareBirmingham$42K
- Jessica WrightBirmingham$33K
- Sara HopperBirmingham$21K
- Andrea SuttonBirmingham$21K
- Olivia ViseHoover$15K
- Lindsay SmithPelham$14K
- Alaina OdomAlabaster$14K
- Holly CluckMontgomery$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.